Stay updated on PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial
Sign up to get notified when there's something new on the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page.

Latest updates to the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.4 is now shown, replacing v3.3.3; this appears to be an internal version update with no visible changes to the study details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedVirginia has been added under Locations as a study site; the page revision is updated to v3.3.3 and the HHS Vulnerability Disclosure link has been removed.SummaryDifference0.2%

- Check52 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; no visible changes to the study details, eligibility criteria, locations, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the temporary government funding status notice from the page, with no changes to core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedThe new screenshot shows layout and user interface updates without changes to core study details like eligibility criteria or outcome measures.SummaryDifference0.5%

- Check102 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

Stay in the know with updates to PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRC-063 vs Lisdexamfetamine in Adult ADHD Driving Clinical Trial page.